Xtant Medical (NYSEAMERICAN:XTNT) Stock Crosses Above Two Hundred Day Moving Average of $0.00

Posted by on Aug 4th, 2022

Shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT – Get Rating) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.55. Xtant Medical shares last traded at $0.52, with a volume of 49,194 shares trading hands.

Xtant Medical Stock Up 1.9 %

The firm has a market capitalization of $45.39 million, a PE ratio of -5.78 and a beta of 1.04. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.27 and a current ratio of 3.81.

Xtant Medical (NYSEAMERICAN:XTNT – Get Rating) last released its quarterly earnings results on Thursday, May 5th. The medical device company reported ($0.03) earnings per share for the quarter. Xtant Medical had a negative net margin of 12.63% and a negative return on equity of 22.21%. The firm had revenue of $12.96 million during the quarter.

Institutional Trading of Xtant Medical

An institutional investor recently bought a new position in Xtant Medical stock. Midwest Professional Planners LTD. acquired a new stake in shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT – Get Rating) in the 1st quarter, according to its most recent 13F filing with the SEC. The fund acquired 40,744 shares of the medical device company’s stock, valued at approximately $28,000. 92.39% of the stock is owned by institutional investors.

Xtant Medical Company Profile

(Get Rating)

Xtant Medical Holdings, Inc develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support bone formation and remodeling; OsteoWrap; and OsteoVive Plus, a growth factor enriched cellular bone matrix.

Read More

Want More Great Investing Ideas?

Receive News & Ratings for Xtant Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical and related companies with MarketBeat.com's FREE daily email newsletter.